What was filed
The case is Vanilla Chip LLC, d/b/a TruHeight v. Vitali Baranouski, individually; Pavlo Bidiuk, individually d/b/a LILYMOON and LM LILYNUTRAMOON; and Ilhama Gusejnova, individually d/b/a Lilymoon Store, No. 2:26-cv-03622 (D. Nev.), filed November 2, 2026, ECF No. 1 (11 pages). Vanilla Chip, a Nevada limited liability company based in Las Vegas, Nevada, says it does business as TruHeight and markets pediatric and adolescent nutritional supplements through its website, Amazon, and other channels. The docket shows the case randomly assigned to Judge Gloria M. Navarro and Magistrate Judge Daniel J. Albregts, and on November 3, 2026 summonses issued to all defendants, an AO 120 report to the USPTO, and a standing order.
The three defendants
The complaint names each defendant for a different link to the brand. It says USPTO records identify Vitali Baranouski, of Minsk, Belarus, as the applicant and owner of Application Serial Nos. 97517373 (LILYMOON) and 98720329 (LILYMOON NUTRATEQUE), and it alleges, on information and belief, that he owns, controls, or directs the LILYMOON brand under which the accused products are marketed. USPTO TSDR lists Vitali Baranouski, an individual and citizen of Belarus, as the applicant for both, for dietary and nutritional supplements and related goods in Class 5, and shows both abandoned for failure to respond to an Office action: LILYMOON was filed July 24, 2022 and abandoned August 9, 2024, and LILYMOON NUTRATEQUE was filed August 27, 2024 and abandoned June 6, 2025. The complaint says Amazon's seller disclosure identifies Pavlo Bidiuk, of Matskivtsi, Ukraine, as the individual operating the Amazon seller LILYMOON / LM LILYNUTRAMOON, and identifies Ilhama Gusejnova, of Irpin, Ukraine, as the individual operating the Amazon seller Lilymoon Store.
What the complaint alleges
The complaint pleads the advertising against the three defendants together. It alleges that as of October 5, 2026 they offered and advertised two products on Amazon. For Height Growth Maximizer Gummies for Kids (ASIN B0FMZMBQCH), it quotes statements including "FORMULATED FOR GROWING KIDS AND TEENS," "LIQUID-FILLED GUMMIES FOR KIDS 4+," "L-Arginine Boosts Human Growth Hormone Production," "MAX GENETIC POTENTIAL 100% Safe," and a "Scientifically developed & proven formula to strengthen the bone density & promote body height growth." For Height Support Supplement (ASIN B0B4SN4TBK), it quotes statements including "All Ages," "HAS BEEN AVAILABLE IN EUROPEAN PHARMACIES SINCE 2019," and a "safe, effective way to grow taller," along with a claim that the product was developed in partnership with a Swiss company the listing calls a medical agency and a German medical quality agency. TruHeight alleges that supplements cannot cause longitudinal bone growth in children, teens, or adults with fused growth plates, that the defendants lack competent and reliable scientific evidence for the "proven" formula claim, and that the "100% Safe" claims are false or misleading because they represent the absence of adverse effects without substantiation. It alleges that the Swiss company is a pharmaceutical company, not a medical agency, and, on information and belief, that neither organization partnered with the defendants or endorsed the product. It alleges the products compete with its own, that it lost sales and suffered price erosion and reputational harm, that it sent a cease-and-desist demand on August 27, 2026 to which the defendants did not respond by the September 6 deadline, and that the advertising remained available at filing.
Claims and relief
Count I is false advertising under Lanham Act section 43(a)(1)(B), 15 U.S.C. § 1125(a)(1)(B). TruHeight seeks injunctive relief under 15 U.S.C. § 1116 and monetary relief under 15 U.S.C. § 1117(a). The prayer asks the court to enjoin publication of the identified statements, require the defendants to remove or correct advertising within their control and to request correction of content they supplied to Amazon, and award TruHeight's damages and the defendants' profits attributable to the violation, interest, reasonable attorney's fees under § 1117(a), and other appropriate relief.